Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
104 hedge funds and large institutions have $624M invested in Myovant Sciences Ltd. in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 39 increasing their positions, 20 reducing their positions, and 29 closing their positions.
95% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 20
1% less funds holding
Funds holding: 105 → 104 (-1)
3% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 29
18% less capital invested
Capital invested by funds: $765M → $624M (-$141M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
80% less call options, than puts
Call options by funds: $5.91M | Put options by funds: $29.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$44.2M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$23M |
| 3 |
BlackRock
New York
|
+$17.7M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.9M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$8.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$47.2M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$15.9M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$14.2M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$9.85M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$6.58M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
Marshall Wace
London,
United Kingdom
| – | -$238K | -8,630 | Closed |
|
|
OC
127
Oppenheimer & Co
New York
| – | -$206K | -7,450 | Closed |
|
|
ASN
128
Advisory Services Network
Atlanta,
Georgia
| – | -$87K | -3,150 | Closed |
|
|
CG
129
Cutler Group
San Francisco,
California
| – | -$53.4K | -2,344 | Closed |
|
|
FC
130
FORA Capital
Miami,
Florida
| – | -$63K | -2,269 | Closed |
|
|
TI
131
tru Independence
Portland,
Oregon
| – | -$19.3K | -700 | Closed |
|
|
MCM
132
Manchester Capital Management
Manchester,
Vermont
| – | -$14K | -500 | Closed |
|
|
AIC
133
Archer Investment Corporation
Carmel,
Indiana
| – | -$2.76K | -100 | Closed |
|
MYOV Hedge Fund Activity: Q1 2021 in Review
104 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q1 2021, worth a combined $624M — down 18% from $765M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of MYOV and 28 opened new positions — a net loss of 1 holder — while 20 trimmed existing stakes and 39 added.
The largest buyer was Wellington Management Group, adding an estimated $44.2M. The largest seller was Victory Capital Management, exiting entirely with an estimated $47.2M sold.
- 104 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q1 2021, down from 105 in Q4 2020.
- Funds reported $624M of Myovant Sciences Ltd. stock for Q1 2021, down 18% quarter-over-quarter.
- 28 funds opened new Myovant Sciences Ltd. positions in Q1 2021 and 29 closed out, a net change of -1 holder.
- The largest Myovant Sciences Ltd. buyer in Q1 2021 was Wellington Management Group, an estimated $44.2M added.
- The largest Myovant Sciences Ltd. seller in Q1 2021 was Victory Capital Management, an estimated $47.2M sold.
Based on aggregated 13F filings for Q1 2021.